Resignation Letters of Executive Director & CEO and Executive Director & COO Disclosed

The company has disclosed the resignation letters of Dr. Ellen Jane Feehan (Executive Director & CEO) and Dr. Neeraja Nagarajan (Executive Director & COO), both ceasing with effect from 24th September, 2026.

Thu 1 Oct 2026

CEO Resignation

Dr. Ellen Jane Feehan (Executive Director & CEO) ceased with effect from 24th September, 2026

CEO Resignation Reason

Unavoidable personal and health reasons; did not take up her role

COO Resignation

Dr. Neeraja Nagarajan (Executive Director & COO) ceased with effect from 24th September, 2026

COO Resignation Reason

Non-alignment in leadership structure, styles and culture, and domicile requirements

What was shared

The company has made a disclosure under Regulation 30 read with Clause 7C of Para A of Part A of Schedule III of SEBI LODR, enclosing the actual communications received from two departing directors. This follows its earlier intimation dated 24th September, 2026 about their cessation.

Who is leaving

• Dr. Ellen Jane Feehan — Executive Director & Chief Executive Officer, cessation effective 24-09-2026.
• Dr. Neeraja Nagarajan — Executive Director & Chief Operating Officer, cessation effective 24-09-2026.

Reasons stated

Dr. Feehan's communication refers to the Executive Employment Agreement executed on 1st July 2026 and signed on 6th July 2026. She stated that due to unavoidable personal and health reasons she was not in a position to take up the assignment and would not join on 1st October 2026, and asked that the communication be treated as termination of the offer under that agreement, ab initio.

Dr. Nagarajan resigned from all roles and responsibilities in the company and other group entity concerns, including participation in the Board, with immediate effect. She cited the non-alignment of Dr. Ellen Feehan as CEO, with whom she was to team up, along with the change in leadership structure, differences in leadership styles and cultures, the operating model, and her domicile requirements given family in the United States. She also noted she had returned the official vehicle.

What this means for investors

Two senior executive positions, CEO and COO, are vacant at the same time. The disclosure shows that one appointee never actually took up the role, while the other stepped down citing leadership alignment issues. Investors may watch for subsequent announcements on how these leadership roles are filled.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.